Literature DB >> 12364335

The lectin domain of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1 is involved in O-glycosylation of a polypeptide with multiple acceptor sites.

Mari Tenno1, Aki Saeki, Ferénc J Kézdy, Ake P Elhammer, Akira Kurosaka.   

Abstract

Mucin type O-glycosylation begins with the transfer of GalNAc to serine and threonine residues on proteins by a family of UDP-GalNAc:polypeptide N-acetylgalactosaminlytransferases. These enzymes all contain a lectin-like (QXW)(3) repeat sequence at the C terminus that consists of three tandem repeats (alpha, beta, and gamma). The putative lectin domain of one of the most ubiquitous isozymes, GalNAc-T1, is reportedly not functional. In this report, we have reevaluated the role of the GalNAc-T1 lectin domain. Deletion of the lectin domain resulted in a complete loss of enzymatic activity. We also found that GalNAc-T1 has two activities distinguished by their sensitivities to inhibition with free GalNAc; one activity is sensitive, and the other is resistant. In our experiments, the former activity is represented by the O-glycosylation of apomucin, an acceptor that contains multiple glycosylation sites, and the latter is represented by synthetic peptides that contain a single glycosylation site. Site-directed mutagenesis of the lectin domain selectively reduced the former activity and identified Asp(444) in the alpha repeat as the most important site for GalNAc recognition. A further reduction of the GalNAc-inhibitable activity was observed when both Asp(444) and the corresponding aspartate residues in the beta and the gamma repeats were mutated. This suggests a cooperative involvement of each repeat unit in the glycosylation of polypeptides with multiple acceptor sites.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12364335     DOI: 10.1074/jbc.M207369200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Probing polypeptide GalNAc-transferase isoform substrate specificities by in vitro analysis.

Authors:  Yun Kong; Hiren J Joshi; Katrine Ter-Borch Gram Schjoldager; Thomas Daugbjerg Madsen; Thomas A Gerken; Malene B Vester-Christensen; Hans H Wandall; Eric Paul Bennett; Steven B Levery; Sergey Y Vakhrushev; Henrik Clausen
Journal:  Glycobiology       Date:  2014-08-25       Impact factor: 4.313

Review 2.  Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.

Authors:  Eric P Bennett; Ulla Mandel; Henrik Clausen; Thomas A Gerken; Timothy A Fritz; Lawrence A Tabak
Journal:  Glycobiology       Date:  2011-12-18       Impact factor: 4.313

3.  Rescue of Drosophila Melanogaster l(2)35Aa lethality is only mediated by polypeptide GalNAc-transferase pgant35A, but not by the evolutionary conserved human ortholog GalNAc-transferase-T11.

Authors:  Eric P Bennett; Ya-Wen Chen; Tilo Schwientek; Ulla Mandel; Katrine ter-Borch Gram Schjoldager; Stephen M Cohen; Henrik Clausen
Journal:  Glycoconj J       Date:  2010-04-27       Impact factor: 2.916

4.  Revisiting the human polypeptide GalNAc-T1 and T13 paralogs.

Authors:  María Florencia Festari; Felipe Trajtenberg; Nora Berois; Sergio Pantano; Leslie Revoredo; Yun Kong; Patricia Solari-Saquieres; Yoshiki Narimatsu; Teresa Freire; Sylvie Bay; Carlos Robello; Jean Bénard; Thomas A Gerken; Henrik Clausen; Eduardo Osinaga
Journal:  Glycobiology       Date:  2016-11-22       Impact factor: 4.313

5.  Conservation of peptide acceptor preferences between Drosophila and mammalian polypeptide-GalNAc transferase ortholog pairs.

Authors:  Thomas A Gerken; Kelly G Ten Hagen; Oliver Jamison
Journal:  Glycobiology       Date:  2008-07-31       Impact factor: 4.313

6.  The catalytic and lectin domains of UDP-GalNAc:polypeptide alpha-N-Acetylgalactosaminyltransferase function in concert to direct glycosylation site selection.

Authors:  Jayalakshmi Raman; Timothy A Fritz; Thomas A Gerken; Oliver Jamison; David Live; Mian Liu; Lawrence A Tabak
Journal:  J Biol Chem       Date:  2008-06-18       Impact factor: 5.157

Review 7.  Polypeptide GalNAc-Ts: from redundancy to specificity.

Authors:  Matilde de Las Rivas; Erandi Lira-Navarrete; Thomas A Gerken; Ramon Hurtado-Guerrero
Journal:  Curr Opin Struct Biol       Date:  2019-01-28       Impact factor: 6.809

8.  Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers.

Authors:  Kishore Guda; Helen Moinova; Jian He; Oliver Jamison; Lakshmeswari Ravi; Leanna Natale; James Lutterbaugh; Earl Lawrence; Susan Lewis; James K V Willson; John B Lowe; Georgia L Wiesner; Giovanni Parmigiani; Jill Barnholtz-Sloan; Dawn W Dawson; Victor E Velculescu; Kenneth W Kinzler; Nikolas Papadopoulos; Bert Vogelstein; Joseph Willis; Thomas A Gerken; Sanford D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-17       Impact factor: 11.205

9.  The lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylation.

Authors:  Thomas A Gerken; Leslie Revoredo; Joseph J C Thome; Lawrence A Tabak; Malene Bech Vester-Christensen; Henrik Clausen; Gagandeep K Gahlay; Donald L Jarvis; Roy W Johnson; Heather A Moniz; Kelley Moremen
Journal:  J Biol Chem       Date:  2013-05-20       Impact factor: 5.157

Review 10.  The Cosmc connection to the Tn antigen in cancer.

Authors:  Tongzhong Ju; Rajindra P Aryal; Matthew R Kudelka; Yingchun Wang; Richard D Cummings
Journal:  Cancer Biomark       Date:  2014-01-01       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.